how to use oral glp 1 FDA Approves Semaglutide as the First Oral GLP-1 Pill? Oral GLP-1: how to win

As the semaglutide patent expiries begin in 2026 across key global markets, Indian pharma companies are racing to capture the opportunity amid rising competition, falling prices & regulatory uncertainty Ekta Bhatra breaks down who stands to gain, the risks ahead, & how GLP-1 drugs could drive the next phase of pharma growth

This isn't a pharma story

Evidence-based hydration targets with exercise and environment adjustments.

Safe & sustainable weight loss based on science

The combination therapy of GLP-1 receptor agonists and metformin demonstrates superior safety over monotherapy, while revealing novel adverse events and demographic-specific risk patterns, thereby offering reliable evidence to inform clinical practice.

Learn about symptoms, treatment options, coping mechanisms, and more.